IL43664A0 - Substituted acylanilides - Google Patents

Substituted acylanilides

Info

Publication number
IL43664A0
IL43664A0 IL43664A IL4366473A IL43664A0 IL 43664 A0 IL43664 A0 IL 43664A0 IL 43664 A IL43664 A IL 43664A IL 4366473 A IL4366473 A IL 4366473A IL 43664 A0 IL43664 A0 IL 43664A0
Authority
IL
Israel
Prior art keywords
substituted acylanilides
acylanilides
substituted
Prior art date
Application number
IL43664A
Other languages
English (en)
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of IL43664A0 publication Critical patent/IL43664A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL43664A 1972-11-24 1973-11-21 Substituted acylanilides IL43664A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30953972A 1972-11-24 1972-11-24
US371452A US3875229A (en) 1972-11-24 1973-06-19 Substituted carboxanilides

Publications (1)

Publication Number Publication Date
IL43664A0 true IL43664A0 (en) 1974-03-14

Family

ID=26976880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43664A IL43664A0 (en) 1972-11-24 1973-11-21 Substituted acylanilides

Country Status (12)

Country Link
US (1) US3875229A (cs)
JP (1) JPS4981332A (cs)
BG (1) BG21392A3 (cs)
DD (1) DD110856A5 (cs)
DE (1) DE2357757A1 (cs)
ES (1) ES420688A1 (cs)
FR (1) FR2207712B1 (cs)
GB (1) GB1446084A (cs)
HU (1) HU169277B (cs)
IE (1) IE38530B1 (cs)
IL (1) IL43664A0 (cs)
NL (1) NL7315903A (cs)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356026A (en) * 1977-06-21 1982-10-26 Stauffer Chemical Company Substituted cyclopropylmethoxy phenyl ureas and their use as herbicides
US4149874A (en) * 1977-06-21 1979-04-17 Stauffer Chemical Company Substituted cyclopropylmethoxy anilides and their use as herbicides
US4230483A (en) * 1977-06-21 1980-10-28 Stauffer Chemical Company Substituted cyclopropylmethoxy phenyl carbamates and thiocarbamates and their use as herbicides
EP0002309B1 (en) * 1977-10-12 1982-12-01 Imperial Chemical Industries Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
DK529378A (da) * 1978-01-09 1979-07-10 Shell Int Research Anilidderivater
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
US4921941A (en) * 1987-07-01 1990-05-01 Schering Corporation Orally active antiandrogens
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
AU4966497A (en) * 1996-11-18 1998-06-10 Yamanouchi Pharmaceutical Co., Ltd. Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
US7518013B2 (en) * 2000-08-24 2009-04-14 University Of Tennessee Research Foundation Selective androgen receptor modulators
US20050038110A1 (en) * 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US6995284B2 (en) * 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US7759520B2 (en) * 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
AU7604798A (en) * 1997-05-30 1998-12-30 University Of Tennessee Research Corporation, The Non-steroidal agonist compounds and their use in male hormone therapy
US6019957A (en) * 1997-06-04 2000-02-01 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US20040186185A1 (en) * 1998-05-07 2004-09-23 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US6998500B2 (en) * 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US6838484B2 (en) * 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US7622503B2 (en) * 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US8008348B2 (en) * 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US8445534B2 (en) * 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US7919647B2 (en) * 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
HRP20030118B1 (en) 2000-08-24 2008-06-30 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
IL154425A0 (en) 2000-08-24 2003-09-17 Univ Tennessee Res H Corp Selective androgen receptor modulators and methods of use thereof
US7102026B2 (en) * 2001-06-13 2006-09-05 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparing and isolating rac-bicalutamide and its intermediates
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
WO2003005889A2 (en) * 2001-07-10 2003-01-23 Ams Research Corporation Surgical kit for treating prostate tissue
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
JP4605557B2 (ja) * 2001-12-06 2011-01-05 ユニバーシティ オブ テネシー リサーチ ファウンデーション 選択的アンドロゲンレセプタ修飾因子を用いた筋萎縮治療
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
CA2689080C (en) * 2002-02-07 2011-07-05 University Of Tennessee Research Foundation Treating benign prostate hyperplasia with sarms
US7803970B2 (en) * 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
JP2006506318A (ja) * 2002-02-28 2006-02-23 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション ハロアセトアミド若しくはアジ化物置換化合物及びその使用方法
CN1700923B (zh) * 2002-02-28 2011-06-15 田纳西大学研究基金会 多取代的选择性雄激素受体调节剂及其使用方法
US7772433B2 (en) * 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
US7344700B2 (en) * 2002-02-28 2008-03-18 University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
EP1534663A4 (en) * 2002-06-17 2006-08-30 Univ Tennessee Res Foundation N-BREAKDOWN SELECTIVE MODULATORS OF THE ANDROGEN RECEPTOR AND METHOD FOR THEIR USE
US7741371B2 (en) * 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
AU2003248052A1 (en) 2002-07-12 2004-02-02 Yamanouchi Pharmaceutical Co., Ltd. N-phenyl-(2r,5s)dimethylpiperadine derivative
AU2003287075A1 (en) * 2002-10-15 2004-05-04 Gtx, Inc. Treating obesity with selective androgen receptor modulators
US20040197928A1 (en) * 2002-10-15 2004-10-07 Dalton James T. Method for detecting selective androgen receptor modulators
WO2004035738A2 (en) * 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
CN1726020A (zh) * 2002-10-16 2006-01-25 Gtx公司 用sarm治疗老年男性雄激素缺乏(adam)相关的疾病
US20060276539A1 (en) * 2002-10-16 2006-12-07 Dalton James T Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
US20040087810A1 (en) * 2002-10-23 2004-05-06 Dalton James T. Irreversible selective androgen receptor modulators and methods of use thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20040167103A1 (en) * 2003-02-24 2004-08-26 Dalton James T. Haloacetamide and azide substituted compounds and methods of use thereof
CA2522874A1 (en) * 2003-12-16 2005-07-07 Gtx, Inc. Prodrugs of selective androgen receptor modulators and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US20060258628A1 (en) * 2004-07-20 2006-11-16 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
EP3056483A1 (en) 2006-08-24 2016-08-17 University of Tennessee Research Foundation Substituted acylanilides and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
EP3510959B1 (en) * 2007-01-02 2021-03-03 AquaBeam LLC Minimally invasive devices for the treatment of prostate diseases
US12290277B2 (en) 2007-01-02 2025-05-06 Aquabeam, Llc Tissue resection with pressure sensing
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
US20080245375A1 (en) * 2007-04-05 2008-10-09 Medtronic Vascular, Inc. Benign Prostatic Hyperplasia Treatments
SI2532648T1 (sl) 2007-05-03 2014-05-30 Yale University Lokalno aktivni "mehki" antiandrogeni
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
ES2769535T3 (es) 2008-03-06 2020-06-26 Aquabeam Llc Ablación de tejido y cauterización con energía óptica transportada en una corriente de fluido
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
EP2907504B1 (en) 2011-02-08 2017-06-28 Halozyme, Inc. Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
EP3351196A1 (en) 2012-02-29 2018-07-25 Procept Biorobotics Corporation Automated image-guided tissue resection and treatment
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
EP3733170A1 (en) 2012-07-13 2020-11-04 Oncternal Therapeutics, Inc. A method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms)
EP2956070A4 (en) 2013-02-14 2016-12-07 Procept Biorobotics Corp METHOD AND DEVICE FOR AQUABLATION AQUABEAM EYE SURGERY
JP6461971B2 (ja) 2013-09-06 2019-01-30 プロセプト バイオロボティクス コーポレイション 飛散パルスを用いた組織切除および処置
EP3160367B1 (en) 2014-06-30 2022-07-13 PROCEPT BioRobotics Corporation Fluid jet tissue resection and cold coagulation (aquablation) apparatus
CN114224438A (zh) 2014-09-05 2022-03-25 普罗赛普特生物机器人公司 与靶器官图像的治疗映射结合的医师控制的组织切除

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268684A (fr) * 1960-08-08 1961-08-04 Basf Ag Procédé pour la production d'amides d'acide beta-hydroxypropionique nu-substituéset de leurs esters avec des acides forts, oxygénés
DE1173082B (de) * 1962-06-06 1964-07-02 Bayer Ag Verfahren zur Herstellung von N-mono-substituierten ª‡-Hydroxycarbonsaeureamiden
US3197503A (en) * 1962-12-14 1965-07-27 Monsanto Co N-(aryl) oxamic acid chlorides
US3201466A (en) * 1963-03-08 1965-08-17 Gulf Oil Corp Substituted cyclopropanecarboxanilide herbicides
NL123536C (cs) * 1963-07-09
DE1189312B (de) * 1963-12-06 1965-03-18 Schering Ag Mittel mit selektiver herbizider Wirkung
NL128941C (cs) * 1964-02-19 1970-06-15
US3426049A (en) * 1965-10-18 1969-02-04 Monsanto Co Nitrotrifluoromethylanilides
US3418345A (en) * 1965-10-18 1968-12-24 Monsanto Co Halonitroanilides
US3462486A (en) * 1966-12-28 1969-08-19 Gulf Oil Corp Method for preparing 3',4'-dichloro-cyclopropanecarboxanilide
US3608087A (en) * 1968-06-21 1971-09-21 Merck & Co Inc Feed compositions
US3723442A (en) * 1970-12-31 1973-03-27 Yoshitomi Pharmaceutical 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
US3720686A (en) * 1971-04-01 1973-03-13 Squibb & Sons Inc Mercaptobenzimidazole derivatives

Also Published As

Publication number Publication date
GB1446084A (en) 1976-08-11
HU169277B (cs) 1976-10-28
AU6270573A (en) 1975-05-22
ES420688A1 (es) 1976-09-01
US3875229A (en) 1975-04-01
JPS4981332A (cs) 1974-08-06
FR2207712A1 (cs) 1974-06-21
FR2207712B1 (cs) 1976-12-03
NL7315903A (cs) 1974-05-28
DD110856A5 (cs) 1975-01-12
IE38530L (en) 1974-05-24
IE38530B1 (en) 1978-03-29
BG21392A3 (cs) 1976-05-20
DE2357757A1 (de) 1974-06-06

Similar Documents

Publication Publication Date Title
IL43664A0 (en) Substituted acylanilides
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
PH13272A (en) Substituted w-pentanorprostaglandins
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU6362373A (en) N-propargylacetanilide herbicedes
AU5993373A (en) N-sulphenylated carbamidoximes
GB1402226A (en) 3-cyanochromones
GB1401579A (en) Indolo-quinolizines
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
ZA7392B (en) Substituted 3-cyanobenzenesulfonamides
AU6332973A (en) Bulbholders
AU5233473A (en) Nitro-imidazolyl-pyrimidines
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
AU5191873A (en) Benzylpyrimidines
GB1401735A (en) Imino-lactams
GB1405254A (en) Bis- substituted-henoxy- propanes
GB1415691A (en) Bracks
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1400667A (en) 4-spirocyclopropyl-androstenes
AU5900173A (en) Thiazolopyrimidines
GB1402045A (en) 11-o-methanesulphonylerythromycins
GB1368732A (en) Trans-polyalkenamers